Internet-delivered psychological treatment for comorbid depression and alcohol/other drug use problems: The SHADE project

image - N6
Date Commenced:
Project Supporters:

Beyond Blue

Drug Type:
Project Members: 
image - Img 6213
Conjoint Associate Professor
Ph 02 4985 4309
Project Main Description: 

Mental health and alcohol/other drug researchers and clinicians must respond to the increased demand for their services, by developing and evaluating treatment programs that address depression and alcohol use disorders, whilst minimising cost and maximising efficient use of clinician time and client outcomes. Available evidence-based treatments provide for single problems (e.g. depression or alcohol misuse) rather than the comorbidity with which clients typically present.  Treatments are often high intensity, require specialist input and training, and are therefore only accessible to a minority of clients.  For these reasons, many clinicians are not able, or willing, to implement these interventions in practice.  The increased availability and use of internet-based programs as a supplement to health care is also a potential solution to well-documented treatment accessibility problems, particularly among people with depression and AOD use comorbidity.

Project Collaborators: External: 

Professor Amanda Baker (University of Newcastle)

Professor Brian Kelly (University of Newcastle)

Dr Kerry Inder (University of Newcastle)


We will conduct a pilot intervention study with an epidemiological cohort of the internet-delivered SHADE treatment program.

Design and Method: 

Participants who report elevated psychiatric distress and hazardous alcohol use will be randomly assigned to assisted vs. unassisted SHADE treatment programs and monitored over a 6-month period.


Recruitment to the project has finished, and data analysis and publications are underway. 


An evidence-based internet-delivered treatment for depression and alcohol use comorbidity.


Findings from this research will result in the development of an effective, cost effective, and acceptable treatment program for people with comorbid alcohol and depressive disorders.

Drug Type: 
Project Status: 
Year Completed: